<?xml version="1.0" encoding="UTF-8"?>
<ref id="B57-molecules-25-00942">
 <label>57.</label>
 <element-citation publication-type="web">
  <article-title>Merckâ€™s Pifeltro (doravirine) and Delstrigo (doravirine/lamivudine/tenofovir disoproxil fumarate) receive FDA approval for use in appropriate adults living with HIV-1 who are virologically suppressed</article-title>
  <day>20</day>
  <month>9</month>
  <year>2019</year>
  <comment>Available online: 
   <ext-link ext-link-type="uri" xlink:href="https://investors.merck.com/news/press-release-details/2019/Mercks-PIFELTRO-doravirine-and-DELSTRIGO-doravirinelamivudinetenofovir-disoproxil-fumarate-Receive-US-FDA-Approval-for-Use-in-Appropriate-Adults-Living-with-HIV-1-Who-Are-Virologically-Suppressed/default.aspx" xmlns:xlink="http://www.w3.org/1999/xlink">https://investors.merck.com/news/press-release-details/2019/Mercks-PIFELTRO-doravirine-and-DELSTRIGO-doravirinelamivudinetenofovir-disoproxil-fumarate-Receive-US-FDA-Approval-for-Use-in-Appropriate-Adults-Living-with-HIV-1-Who-Are-Virologically-Suppressed/default.aspx</ext-link>
  </comment>
  <date-in-citation content-type="access-date" iso-8601-date="2019-11-06">(accessed on 6 November 2019)</date-in-citation>
 </element-citation>
</ref>
